Purple Biotech Ltd. (NASDAQ: PPBT)
$2.5900
+0.0500 ( +4.44% ) 38.7K
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.